[go: up one dir, main page]

ES2192234T3 - Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos. - Google Patents

Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.

Info

Publication number
ES2192234T3
ES2192234T3 ES96940698T ES96940698T ES2192234T3 ES 2192234 T3 ES2192234 T3 ES 2192234T3 ES 96940698 T ES96940698 T ES 96940698T ES 96940698 T ES96940698 T ES 96940698T ES 2192234 T3 ES2192234 T3 ES 2192234T3
Authority
ES
Spain
Prior art keywords
acids
arilpropionic
pharmaceutical compositions
compositions containing
containing salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96940698T
Other languages
English (en)
Inventor
Marco Gentile
Luigi Boltri
Gaetano Clavenna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dompe SpA
Original Assignee
Dompe SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe SpA filed Critical Dompe SpA
Application granted granted Critical
Publication of ES2192234T3 publication Critical patent/ES2192234T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA PARA LA ADMINISTRACION PARENTERAL QUE POSEE PROPIEDADES ANTI-INFLAMATORIAS Y ANALGESICAS, QUE CONTIENE COMO PRINCIPIO ACTIVO LAS SALES DE ALQUILAMONIO DE ACIDOS 2
ES96940698T 1995-12-28 1996-12-23 Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos. Expired - Lifetime ES2192234T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI002777A IT1277741B1 (it) 1995-12-28 1995-12-28 Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici

Publications (1)

Publication Number Publication Date
ES2192234T3 true ES2192234T3 (es) 2003-10-01

Family

ID=11372830

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96940698T Expired - Lifetime ES2192234T3 (es) 1995-12-28 1996-12-23 Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.

Country Status (23)

Country Link
US (1) US5895789A (es)
EP (1) EP0814797B1 (es)
KR (1) KR19980702301A (es)
CN (1) CN1082812C (es)
AR (1) AR005308A1 (es)
AT (1) ATE232096T1 (es)
AU (1) AU1069897A (es)
BR (1) BR9607422A (es)
CA (1) CA2213232A1 (es)
CZ (1) CZ290646B6 (es)
DE (1) DE69626103T2 (es)
DK (1) DK0814797T3 (es)
EA (1) EA000599B1 (es)
ES (1) ES2192234T3 (es)
HU (1) HU224685B1 (es)
IT (1) IT1277741B1 (es)
NO (1) NO973921D0 (es)
PL (1) PL187170B1 (es)
PT (1) PT814797E (es)
SI (1) SI9620023A (es)
SK (1) SK282579B6 (es)
TR (1) TR199700869T1 (es)
WO (1) WO1997024114A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298214B1 (it) * 1998-01-28 1999-12-20 Dompe Spa Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche.
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
ES2189682B1 (es) * 2001-12-11 2004-04-01 Laboratorios Del Dr. Esteve, S.A. Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea.
EP1558234B1 (en) * 2002-10-25 2007-05-23 Dompé S.P.A. Painless injectable compositions containing salt of 2-arylpropionic acids
US7090859B2 (en) * 2002-12-13 2006-08-15 Ronald Thomas Haas Ketoprofen compositions and methods of making them
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006239313A1 (en) * 2005-04-28 2006-11-02 Najib Babul Methods and compositions for treating pain
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
EP1983983A4 (en) * 2006-02-06 2009-11-25 Pharmaceutical Solutions Inc NON-STEROIDAL, ANTI-FLAMMATORALLY ACTIVE ORAL POWDER AND LIQUID PREPARATIONS FOR ADMINISTRATION IN ANIMALS
JP5242543B2 (ja) * 2006-03-16 2013-07-24 ノバルティス アーゲー 味をマスキングした活性薬剤を含有する固体剤形
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
FR2950533B1 (fr) * 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
FR2971712B1 (fr) * 2011-02-22 2016-06-10 Map France Solution stable de ketoprofene pour injection intraveineuse
US8415337B1 (en) 2011-03-06 2013-04-09 Recordati Rare Diseases Inc. Ibuprofen compositions and methods of making same
CN102381986A (zh) * 2011-07-25 2012-03-21 南京特丰药业股份有限公司 一种右旋布洛芬氨丁三醇盐及其口服溶液的制备方法
JP6174579B2 (ja) * 2011-08-04 2017-08-02 オメロス コーポレーション 安定な注射用抗炎症性溶液
CN102362857A (zh) * 2011-11-22 2012-02-29 陆荣政 一种右旋布洛芬注射液及其制备方法
GR1008942B (el) * 2015-10-14 2017-02-06 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση
EP3716944A1 (en) 2017-11-30 2020-10-07 Aziende Chimiche Riunite Angelini Francesco A.C.R. Stable liquid composition of ketoprofen, salts and enantiomers thereof
EP3670489A1 (en) 2018-12-21 2020-06-24 Dompé farmaceutici S.p.A. Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
DE2830921A1 (de) * 1978-07-14 1980-01-31 Bbc Brown Boveri & Cie Verfahren zum verhindern von sintererscheinungen an schmiedebloeckchen
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE3270988D1 (en) * 1981-07-20 1986-06-12 Upjohn Co Use of ibuprofen or flurbiprofen for the manufacture of a medicament for treating respiratory disorders
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
EP0267321B1 (de) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Ibuprofen enthaltendes Arzneimittel
US4868214A (en) * 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US4887620A (en) * 1988-04-26 1989-12-19 Better Life International, Inc. Composition and method to provide organoleptic bite in a composition for human consumption
IT1255007B (it) * 1991-07-01 1995-10-11 Altergon Sa Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
FR2687915B1 (fr) * 1992-02-28 1995-05-05 Rhone Poulenc Rorer Sa Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r).
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
US5808069A (en) * 1993-03-09 1998-09-15 Dompe' Farmaceutici Spa Salts of 2-(3-benzoylphenyl) propionic acid with organic bases and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
US5895789A (en) 1999-04-20
SK113097A3 (en) 1998-02-04
EA199700201A1 (ru) 1998-02-26
EP0814797A1 (en) 1998-01-07
DK0814797T3 (da) 2003-05-26
AR005308A1 (es) 1999-04-28
PT814797E (pt) 2003-06-30
AU1069897A (en) 1997-07-28
NO973921L (no) 1997-08-26
EP0814797B1 (en) 2003-02-05
IT1277741B1 (it) 1997-11-12
CA2213232A1 (en) 1997-07-10
DE69626103D1 (de) 2003-03-13
HUP9801048A1 (hu) 1998-10-28
HU224685B1 (hu) 2005-12-28
CZ290646B6 (cs) 2002-09-11
SK282579B6 (sk) 2002-10-08
MX9706237A (es) 1997-11-29
TR199700869T1 (xx) 1997-12-21
BR9607422A (pt) 1998-06-23
EA000599B1 (ru) 1999-12-29
CN1176596A (zh) 1998-03-18
CZ264397A3 (en) 1997-11-12
PL322165A1 (en) 1998-01-19
SI9620023A (sl) 1998-02-28
DE69626103T2 (de) 2003-12-04
HK1008777A1 (en) 1999-07-16
ITMI952777A0 (es) 1995-12-28
KR19980702301A (ko) 1998-07-15
CN1082812C (zh) 2002-04-17
NO973921D0 (no) 1997-08-26
PL187170B1 (pl) 2004-05-31
ITMI952777A1 (it) 1997-06-28
ATE232096T1 (de) 2003-02-15
WO1997024114A1 (en) 1997-07-10
HUP9801048A3 (en) 2000-07-28

Similar Documents

Publication Publication Date Title
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
MX9701342A (es) Formulacion cosolvente de tirilazad para administracion parenteral.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2159591T3 (es) Composicion de liberacion controlada.
HN2001000224A (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
MY115662A (en) Novel compounds with analgesic effect
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
UY26372A1 (es) &#34;imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen &#34;
AR007040A1 (es) Compuestos de eritromicina 6-0-sustituida, composiciones farmaceuticas, uso de dichos compuestos para preparar medicamentos y procedimiento para supreparacion
ES2034926T1 (es) Composiciones farmaceuticas orales liquidas con actividad anti-inflamatoria.
ES2142432T3 (es) Forma de dosificacion de la gepirona.
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
BR0107899A (pt) Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
ES2126127T3 (es) Composicion farmaceutica liquida para uso oral, que contiene acido 2-(4-isobutilfenil)propionico.
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
ES2195538T3 (es) Composicion farmaceutica que comprende una combinacion de isomeros dextro y levo de sotalol.
BR0108313A (pt) Composição farmacêutica para injeção intramuscular contendo loxoprofeno
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
DE69813263T2 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
AR004503A1 (es) Uso de l-carnitina, l-carnitinas acilicas en las cuales el gruo acilo, lineal o ramificado, tiene entre 2 y 6 atomos de carbono y sus salesfarmaceuticamente aceptables, y composiciones farmaceuticas que comprenden tales compuestos
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase